СПИСОК ЛИТЕРАТУРЫ

1. Аникин С.Г. Ретроспективное исследование факторов риска переломов бедра у женщин/ С.Г. Аникин // Остеопороз и остеопатии.- 2001.- №1. - С.2-4.

2. Баранова И.А. Остеопороз у больных бронхиальной астмой /И.А.

3. Беневоленская Л.И., Финогенова С.А. Генетика остеопороза: исследование значимости генетических факторов в детерминации заболевания (обзор литературы)/ Л.И. Беневоленская, С.А. Финогенова //Остеопороз и остеопатии. -1999.-№2,- С.23-25.

4. Глобальная стратегия лечения и профилактики бронхиальной астмы / под. ред. Е.Г. Чучалина.- М.:-Атмосфера, 2002.- 160 с.

5. Глобальная инициатива по хронической обструктивной болезни легких/ под.. ред. Е.Г. Чучалина.- М.:-Атмосфера, 2003.- 96 с.

6. Дамбахер М.А., Шахт Е. Остеопороз и активные метаболиты витамина D: мысли которые приходят в голову/ М.А. Дамбахер, Е. Шахт Е. Пер. с англ. M.S.Y.S. Publishing, 1996.- 139 с.

7. Емельянов А.В. Механизмы развития стероидного остеопороза у больных бронхиальной астмой / А.В. Емельянов, С.Э. Шевелев, Б.А. Мурзин, В.И. Амосов // Терапевт, арх.- 2000.- №5.- С.58-59.

8. Ермакова И.П. Современные биохимические маркеры в диагностике остеопороза / И.П. Ермакова, И.А. Пронченко // Остеопороз и остеопатии.- 1998.-№2.- С.24-26.

9. Каминский Ю.В. Гистоморфологические исследования костной ткани при дыхательной недостаточности / Ю.В. Каминский, Е.А. Кочеткова, Е.А. Коцюрбий и др.// Остеопороз и остеопатии.- 2001.- №1.- С.12-15.

10. Кочеткова Е.А. Остеопороз и хроническая обструктивная болезнь легких/ Е.А. Кочеткова, Б.ИГельцер И Владивосток:- Дальнаука, 2003.- 234 с.

П.Лежнина М.Б. Остеопоротические переломы тел позвонков у больных стероидозависимой бронхиальной астмой /М.Б. Лежнина, О.М. Лесняк, А.И.

Пивень, М.К. Лебедева //Клин, медицина.- 2000.- №9.- С.28-32.

12. Михайлов Е.Е. Частота переломов проксимального отдела бедренной кости и дистального отдела предплечья среди городского населения России/ Е.Е. Михайлов, Л.И. Беневоленская, С.Г. Аникин //Остеопороз и остеопатии. 1999.- №3.- С.2-6.

13. Насонов Е.Л., Скрипникова И.А., Насонова В.А. Проблема остеопороза в ревматологии/ Е.Л. Насонов, И.А. Скрипникова, В.А. Насонова.- М.:”СТИН”, 1997. - 429с.

14. Насонов Е.Л. Глюкокортикоидный остеопороз: современные рекомендации / Е.Л. Насонов //Consilium medicum.- 2002.- №8.- С.403-408.

15. Оганов В.С. Гипокинезия - фактор риска остеопороза / В.С. Оганов // Остеопороз и остеопатии. - 1998. - №1. - С.13-17.

16. Риггс Б.Л., Мелтон НГЛ.Дж. Остеопороз./ Б.Л. Риггс, ШЛ.Дж. Мелтон. Пер. с англ. М.- Санкт-Петербург: ЗАО “ БИНОМ ’’/‘Невский диалект”, 2000.- 560 с.

17. Рожинская Л.Я. Минеральная плотность ткани при эндогенном и экзогенном гиперкортицизме /Л.Я. Рожинская, Е.И. Марова, А.И. • Бухман и др.// Остеопороз и остеопатии.- 2000.- №2.-С.12-17.

18. Руководство по остеопорозу/ под ред. Л.И. Беневоленской.- М.: БИНОМ. Лаборатория знаний, 2003.- 524 с.

19. Скрипникова И.А. Остеопороз, индуцируемый клюкокортикоидами/ И.А. Скрипникова, Е.Л. Насонов, В.А. Насонова И Клин, фармакол. и тер.- 1996.- №1.- С.9-15.

20. Тугуд Дж. X. Побочные эффекты терапии ингаляционными стероидами при астме/ Дж. X. Тугуд //Тер Арх.-1995.- №6,- С.76-80.

21. Франке Ю. Остеопороз / Ю. Франке, Г. Рунге // пер. нем. М.: Медицииа,-

1995. -С. 11-58.

22. Чучалин А.Г. Хронические обструктивные болезни легких/ А.Г. Чучалин, //.- М. - 1998.- 509 с.

23. Чучалин А.Г. Бронхиальная астма: руководство для врачей / А.Г Чучалин, Б.Л. Медников, А.С. Белевский и др. //Cosilium medicum.- 2000.- V.2.- N.I.- P.l 1-20.

24. Adachi J.D. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year follow-up/ W.G Bensen., F. Bianchi, et al Hi. Reumatol.-

1996.- V.23(6).- P.995-1000.

25. Adachi J.D. Corticosteroid-induced osteoporosis/ J.D.

1997.-V. 137.-P.209-217.

26. Adami S. Relationship between lipid profile and bone mass in healthy males/ S. Adami, V. Braga, M. Zamboni, et all.. // Bone.- 2001.- V.28.- 5(suppl).- P418W.- S.201.

27.. Adami S., Anabolic steroids in corticosteroid-induced osteoporosis/ S.Adami M. Rossini //Wien.Med. Wochensch.- 1993.- V.44.- P. 395-397.

28. Agertofl L. Bone mineral density in children with astma receiving long-term treatment with inhaled budesonide/ L. Agertofl, S. Pedersen // Am. J. Respir. Crit Care. Med.- 1998.- V.157.- P. 178-183.

29. Alan R.F., Buijs W.G., van Eming L.G., et al. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content/ R.F. Alan, W.G. Buijs, L.G. van Eming, et al. //Calcif. Tissue. Int. // 1993.- V.52.- P.5-9.

30. Allen D.B. Growth suppression by glucocorticoid therapy/ D.B. Allen // Endocrinol. Metabol. Clin. North. Am.- 1996.- V.25.- P. 699-717.

31. Allen D.B. Liminations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids/ D.B. Allen//Allergy.- 1999.- V.54.-P.29-34.

32. Aman S. Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis/ S. Aman, M. HaKala, J. Silvennoinen, et al. //J. Rheumatol.- 1998.- V.63.- P.344-348.

33. American College of Reumatology and Committtee on Clucocorticoid-induced Osteoporosis. Recommendation for prevention and treatment of glucocorticoid- induced osteoporosis // Arthritis & Rheumatism.- 2001.- V.44(7).- P.1496-1503.

34. Aris R.M. Abnormal bone turnover in cystic fibrosis adults/ R.M. Aris, D.A. Ontjes, H.E. Buell, et all. // Oseoporos. Int.- 2002.- V.13.- P.151-157.

35. Assessment of fracture risk and its application to screening for posmenopausal osteoporosis. Report of a WHO Study Group AVHO Tech. Report Series, 1994. -

n$

843 р.

36. Ayres J.G. A comparison of the safety and efficacy of fluticasone propionate (1 mg/day and 2 mg/day) and budesonide (1.6 mg/day) in the treatment of severe asthma [abstact] Z J.G.

37. Backman K.S. Airway obstruction in patient with long-term asthma consistent ith irreversible asthma/ K.S. Backman, P.A. Greenberg,- R. Paterson // Chest- 1997.- V.112.- P. 1234-1240.

38. Balint E. Glucose-induced inhibition of in vitrobone mineralization/ E. Balint, P. Szabo, C.F. Marshall, S.M. Sprague // Bone.- 2001.- V.28.- P. 21-28.

39. Baranova I. Study of bone mineral density in patients with bronchial astma on glucocorticoid therapy/1. Baranova, N. Toroptzova, K. Gadjiev, et al. //Bone.- 2001.- V. 28.- P457W.-S202. K.

40. Barnes P.J. Chronic obstructive pulmonary disiease I P.J. Barnes // N. Engl. J. Med.- 2000.-V.343.-P.269-280.

41. Bayer M. The bone’s disorder in children treated for asthma bronchiale/ M. Bayer //Bone.- 2001.- V. 28.- P453W.-S201. K.

42. Bekker P.J. Osteoprotegerin (OPG) has potent and sustained anti-resorptive activity in postmenopausal women I PJ. Bekker, D. Holloway A. Nalanishi, et al. //J. Bone Miner. Res.-1999.-V.14(Suppl. 1).- S.180.

43. Bergot C. Hip fracture risk and proximal femur geometry from DXA scans/ C. Bergot, V. Bousson, A. Meunier, et al. //Osteoporos. Int.- 2002.- V.13.- P. 542-550.

44. Black D.M., Steinbuch M., Palermo I., et al. An assessment tool for predicting fracture risk in postmenopausal women //Osteoporosis Int.- 2001. - Vol.12. -P.519- 528.

45. Boootsma G.P. Fluticasont propionate does not influence bone metabolism in contrast to beclamethasone dipropionate/ G.P. Boootsma, P.N.R. Dekhuijzen, J. Festen, et al. // Am Respir Crit Care Med.- 1996.- V.153.- P.924-930.

46. Borgquist L. Cost of hip fracture: reabilitation of 180 patients in primary health care/ L. Borgquist, G. Lindelow, R-G. Thomgren H Acta. Orthop. Scand.- 199 V.62.-

Р.39-48.

47. Bomefalk Е. Age-dependet effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma/ E. Bomefalk, I. Dahlen, K.

48. Brown J.P. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada I J.P. Brown, R.G. Josse //CMAJ.-2002.-V. 167(1 Osuppl.).- S1-S34.

49. Browner W.S. Non-trauma mortality in elderly women with low bone mineral density. Stady of Oseoporosis Fractures Reseach Group. К/ W.S. Browner, D.G. Seeley, T.M. Vogt, S. R. Cummings // Lancet.-1991.- V.338.- P.355-358.

50. Buckley L.M. Variations in physicians judigments about corticosteroid induced osteoporosis by physician speciality/ L.M. Buckley, M. Marguez, J.O. Hudson, et al. // J. Rheumatol.- 1998.- V25.- P.2195-2202.

51. Buckley L.M. Prevention of corticosteroid-induced osteoporosis/ L.M. Buckley, M. Marguez, R. Feezor, et al. // Arthritis Rheum.- 1999.- V.42.- P.1736-1739.

52. Canalis E. Editorial: Inhibitory actions of glucocorticoids on skeletal growth. Is local insulin-like growth factor 1 to blame? / E. Canalis I I Endocrinology.- 1998.- V.139.-P.3041-3042.

53. Canalis E. Glucocorticoid-induced osteoporosis/ E. Canalis // Cur. Opin. Endocrino.l Difbetes.- 2000.- V.7.- P. 320-324.

54. Carbonare L.D. Comparison of trabecular bone microarchitecture and remodeling in clucocorticoid-induced and postmenopausal osteoporosis/ L.D. Carbonare, M.E. Arlot, P.M. Chavassieux, et al. // J. Bone. Miner. Res.- 2001,- 16.- V.P. 97-103.

55. Centrella M. Glucocorticoid control transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone/ M. Centrella, T.L. McCarthy, E. Canalis // Mol. Cell. Biol.-1991.- V.l 1.- P.4490-4496.

56. Chen T.L. Glucocorticoid regulation opf 1.25 (OH)2 -vitamin D3 receptors in cultured mouse bone cells / T.L. Chen, E. Cone Morey-Holton, D. Feldman // J. Bio.l Chem.- 1982.- V.257.- P.13563-13569.

57. Chen T.L. I a25-Dihhydroxyvitamin D3 receptors in cultured rat osteoblast-like

cells: glucocorticoid treatment increases receptor content/ T.L.

58. Chyum Y.S. Opposing effects of prostaglandin E2 and cortisol in bone growth in organ culture/ Y.S. Chyum, L.G. Raisz // Clin. Res.- 1982.- V.30.- P.387A.

59. Clark K. Alcohol dependens, smoking status, reproductive characteristics, and bone mineral density in premenopausal women/ K. Clark, M.R. Sowers // Res. Nurs. Health.- 1996.- V. 19.- P. 399-408.

60. Conaway H.H. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones/ H.H. Conaway, D. Gigirone, U.H. Lerner//J. Endocrinol.- 1997.- V.155.- P. 513-521.

61. Corradino R.A. Positive cotranscriptional regulation of intestinal calbindin -D28K gene expression by 1.25 dihydroxyvitamin D3 and glucocorticoids/ R.A. Corradino, C.S. Fullmer // Endocrinology.- 1991.- V. 128.- P.944-950.

62. Corradino R.A. Tissue-specific regulation of shell gland calbindin D28K biosyntesis buy estradiol in precociouslymatured , vitamin D-depleted chicks/ R.A. Corradino,

C. A. Smith, L.P. Krook, C.S-. Fullmer//Endopcrinology.- 1993.- V.132.- P.193-198.

63. Cummings S.R. Bone density at various sites for prediction of hip fractures/ S.R. Cummings, D.M. Black, M.C. Nevitt // Lancet.- 1993.- V.341.- P.72-75.

64. Cosman F. High-dose glucocorticoids in multiple selerosis patientsexertdirect effects on kidney and skeleton / F. Cosman, J. Nieves, J. Herbert, et al. // J. Bone Miner. Res..- 1994.-V.9.-P.1097-1105. •

65. De Laet C.E. Prevention of osteoporosis fractures in dutch men and women: a cost effectiveness evaluation/ C.E. De Laet., H.A. Pols //Bone.- 2001.- V 5(suppl).- SC13T.-S.93.

66. Delmas P.D. The use of biochemical markers of bone turnover in osteoporosis I P.D. Delmas, R.Eastel, P. Gamero, et al. //Osteoporosis Int.- 2000.- V.(suppl.6.).-P.2-17.

67. Dempster D.W. Bone histomorphometry in glucocorticoid-induced osteoporosis /

D. W. Dempster// J. Bone. Miner. Res.- 1989.- V.5.- P.137-141.

68. Dennison E. Determinants of bone loss in elderly men and women a prospective population-based study/ E. Dennison, R. Eastell, G.H. Fall, et al. // Osteoporos. InL-

1999. -V. 10.-Р. 384-391. .

69. De Nijs R.N.J. Prevalence of vertebral deformities in corticosteroid treated patients with rheumatoid arthritis/ R.N.J. De Nijs, J.W.G. Jacobs, W.F. Lems, et al. И Bone.-

1998. - V.23(Suppl).- S298.

70. Dietrich J.W. Effect of glucocorticoids on fetal rat bone collagen synthesisin vitro/ J.W. Dietrich, T.M. Canalis, D.M. Maina, L.G. Raisz // Endocrinology.- 1979.- V.104.- P.715-721

71. Doerr P. Cortisol-induced suppression of plasma testosterone in normal adult males/ P. Doerr, K.M. Pirke US. Clin. Endocrinol. Metab.- 1976.-V.43.- P.774-779.

72. Dovio A., Masera R.G., Sartori M.L., at al Autocrine' up-regulation of glucocorticoid reception by interleukin-6 in human osteoblast-like cells/ A. Dovio, R.G. Masera, M.L. Sartori, at al // Calcif.Tissue. Int.-2001.- V.69.- P.293-298.

73. Dykman T.R. Evaluation of-factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases/ T.R Dykman, O.S. Gluck, W.A. Murphy, et al7/Arthritis Rheum.- 1985.- V.28.- P. 362-368.

74. Eastell R. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update/ R. Eastell, D.M. Reid, J. Compston, et al. // J. Intern. Med.- 1998.- V.244.- P.271-292.

75. Eastell R. Bone markers: biochemical and clinical perspectives/ R. Eastell, M. Bauman, N.R. Hoyle, LAVieczorek // Roche. Martin Dunitz Ltd, 2001.- 252 p.

76. Ebeling P.R. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids/ P.R. Ebeling, B. Erbas, J.L. Hopper, et al. // Bone. Miner. Res.- 1998.- V.13.- P.1283-1289.

77. Elkin S.L. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study/ S.L. Elkin, A. Faimey, S. Burnett, et al. // Osteoporos. Int-2001.- V.12.- P. 366-372.

78. Fclsenberg D. Prevalence of vertebral osteoporosis fractures in males/ D. Felsenberg, W. Growin // World Congress on osteoporosis.- 1996. Abstract on disk.

79. Felson D.T. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study/ D.T. Felson, Y. Zhang, M.T. Hannan, JJ

Anderson // J. Bone Miner. Res. - 1993. - V.8. - №5. P.567-573.

80. Fujimoto H. Hypoxemia is a risk factor for bone mass loss/ H. Fujimoto, K. Fujimoto, A.Ueda, M. Ohata Hi Bone Miner Metab.-1999.- V.l50.- P. 967-972.

81. Gamero P. Markers of bone turnover for the prediction of fracture risk / Р/ Gamero // Osteoporos. Int.- 2000.- V.l l(suppl. 6.).- P.55-65.

82. Glerup H. Hypovitaminosis D myopathy without biochemical sings of osteomalacic bone involvement/ H. Glerup, K. Mikkelsen, L. Poulsen, et a!7/ Cal ci f. Tissue. Int.-

2000. - V.66.- P.419-420.

83. Gluck O.S. Bone loss in adults receving alternate glucocorticoid therapy: a comparison with daily therapy/ O.S. Gluck, W.A. Murphy, T.J. Hahn, B. Hahn //Artritis. Rheum.-1981.- V.24.- P.892-898.

84. Goldshalk M. Glucocorticoid descrease vitamin D receptor numbers and gene expression in human osteosarcoma cells/ M. Goldshalk, J.R. Levy, R.W. Downs Jr. //J. Bone. Miner. Res.- 1992.- V.7.- P.21-27.

85. Gotzsche P.S. Prednisolone versus placebo and non-steroidal anti-inflammatoiy drugs in rheumatoid arthritis / P.S. Gotzsche, H.K. Johansen // Br. Med. J.- 1998.- V.316.- P.789-790.

86. Gough A.K.. Generalized bone loss patients with early rheumatoid arthritis/ A.K Gough, J. Lilley, S. Eyre, et al. //Lancet- 1994,- V.344.- P.23-27.

87. Gray R.E. A double-blind study of deflazacort and prednisone in patients with cronic inflammatory disorders/ R.E. Gray, S.M. Doherty, J. Galloway, et all. //Arthritis Rheum.- 1991.- V.34.- P.287-295.

88. Gronowicz G. Glucocorticoids inhibit the attachement of osteoblasts tobone extracellular matrix proteins and decrease beta 1-integrin levels / G. Gronowicz, M.B. McCarthy. // Endocrinology.-1995.- V.136.- P.598-608.

89. Gross NJ. Extrapulmonary effects of chronic obstructive pulmonary disease/ N.J. Gross // Curr. Opin. Pulm. Med.- 2001.- V.7(2).- P.-84-92.

90. Guddbjomsson B. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice/ B. Guddbjomsson, U.I. Juliusson, F.V. Guddjonsson //Annals of the Rheumatic

Diseases.- 2002.-V. 61.- P.32-36.

91. Gugliemi G. Quantitative computed tomografy at the axial and peripheral skeleton/

G. Gugliemi, P. Schneider, T.F. Lang, et al //Eur. Radiol.- 1997.- V.7.- S.P. 32-42.

92. Hahn T.J. Effect of chronic corticosteroid administration on diaphyseal and metaphysical bone mass / T.J. Hahn, V.C. Boisseau, L.V. Avioli // J. Clin. Endocrinol. Metab.- 1977.- V.39.- P.274-282.

93. Hahn T.J. Altered mineral metabolism in glucocorticod-indused osteopenia: effect of 25-hydroxyvitamin D administration/ T.J. Hahn, L.R. Halstead, S.L. Teitelbaum, B.H. Hahn // BNJ. Clin. Invest.- 1979.- V.64.- P.655-665.

94. Hanania N.A. Dose-related descrease in bdne density among asthmatic patients treated with inhaled corticosteroids/ N.A. Hanania, K.R. Chapman, W.C. Sturtridge, et al. // J. Allergy. Clin. Immunol.- 1995.- V.96.- P.571-579.

95. Harris M. Bone mineral density in prepubertal asthmatics receving corticosteroid treatment / M. Harris, S. Hauser, T.V. Nguyen, at all. // J. Paediatr. Child. Health.- 2001 .-V.37.-P.67-71.

96. Harrison T.W. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects / T.W.Harrison, A.Wisniewski, J.Honour, A.E. Tatterfield // Thorax. - 2001. -V.56.- №3.-P.186-191.

97. Hattersley A.T. The effect of long-and short-term corticosteroid on plasma calcitonin and parathyroid hormone levels / A.T. Hattersley, K. Meeran, J. Burrin, et al.//Calcif. Tissue Int. - 1994.-V.54.-P. 198-202.

98. Heuck C. Adverse effects of inhaled budesonide (800mg) on growth and collagen turnover in children with ashma: a double-blind comparison of once-daily versus twice-daily administration/ C. Heuck, O.D. Wolthers, G. Kollerup, et al. //J. Pediatr.- 1998.- V.133.- P.608-612.

99. Hosmer W.p. Fracture before menopause: a red flag for physicians/W.D. Hosmer,

H.K. Genant, B.M. Landgren // Osteoporos. Int- 2002.-V. 13.- P.337-341.

100.Hosking D.J. Effects of corticosteroids on bone turnover /D.J. Hosking //Respiratory Medicine.- 1993.- V.87.-Suppl A. P.3.

101.Hofbauer L.C. Srimulation of osteoprotegerin ligand and inhibition osteoprotegerin production by glucocorticoids in human osteoblsstic lineage cells: Potencial paracrine mechanisms of glucocorticoids-induced osteoporosis / L.C. Hofbauer, F. Cori, B.L. Riggs, et al. // Endocrinology.- 1999.- V.14. - P.4382-4389.

102.Ip M. Descreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids/ M. Ip, K. Lam, A. Kung, M. Ng. //Chest- 1994.- V.105.- P. 1722-1727.

103.Iqbal D. Eclining bone mass in men chrinic pulmonary disease / F. Igbal , J. Michaelson, L. Tthaler// Chest.- 1999.-V. 116(6).-P. 1616-1624.

104.Ishida Y. Glucocorticosteroid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation / Y. Ishida, J.N. Heersche //J. Bone Miner. Res.- 1998.- V.13.-P.1822-1826.

105.Ishida Y. Pharmocologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypotesis/ Y. Ishida, J.N. Heersche // Osteoporos. Int-2002.- V.13.- P.601- 605.

106.Israel E. / E. Israel, T.R., Banerjee, G.M. Fitzmaurice, et al. // N. Engl. J. Med.-

2001. -V.345.- P.941-947.

107.Jagbal S.B. The impact of consequences of hip fracture in Ontario/ S.B. Jaglal, P.G. Sherry, J. Schaatzker // Can. J. Surg.- 1996.-V. 39.- P. 105-111

108.Java id M.K. Comparison of calcaneal ultrasound and DXA to assess the risk of corticosteroid-induced osteoporosis a cross-sectional study/M.KJavaid, P.R. McCrudden, P. Taylor, et al. И Osteoporos. Int.- 2001.- V.12.- P.788-793.

109.Jaworsky M. Evaluation of bone mass and bone quality in children with asthma treated with anti-inflamatory steroids DXA and QUS: preliminary results/ M. Jaworsky, K. Nowacka, R.S. Lorenc //Bone.- 2001,- V.28(suppl).- P454W.- S202.

110.Johansson C. Bone mineral density is a predictor of survival/ C. Johansson, M. Black, O. Jhonell, et al. // Calcif. Tissue Int.- 1998.-V. 63.- P.190-196.

111.Jones A. Inhaled corticosteroid effects on bone metabolism in asthma and mild obstructive pulmonary disease / A. Jones, J.K. Fay, M.Burr, et al. // Cocrane Library.-

2002. - V.3.- CD003357.

112.Jonsson K.B. Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts/ K.B. Jonsson, S. Ljunghall, O. Karlstrom, et al // Biosci. Rep.- 1993.- V.t3.- P.297-302.

113.Jux C. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF- receptor in cultured rat chondrocytes / C. Jux, K. Leiber, U. Hugel, et al. // Endocrinology.- 1998.- V. 139,- P.3296-3305.

114.Keene G.S. Mortality and morbility after hip fracture / G.S. Keene, M.J. Parker, G.A. Pryor//BMJ.- 1993,- V.307.- P.1248-1250.

115.Kerstjens H.F. Effect of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction / H.F. Kerstjens, D.S Postma, J.J.Van-Doormaal //Thorax.- 1994.-V.49.- P.652-203.

116.Kiel D.P. The effect of smocking at different life stages on bone mineral density in elderly men and women/ D.P. Kiel, Y. Zhang, M.T. Hannan, et al. // Osteoporos. Int.- 1996.-V.6.-P.240-248.

117.Kroger H. Incresed risk of vertebral deformietes in women with rheumatoid arthritis / H. Kroger, J. Jurvelin, H.S. Barden, et al. // Bone .- 1998.- V.23(Suppl).- S391.

118.Laan R.F. Differential effects of glucocorticoids on cortical appendicular and cortrical vertebral bone mineral content / R.F. Laan, W.C. Buijs, L.G. van Eming, et al. И Calcif. Tissue Int.- 1993.- V.52.- P.5-9.

119.Lau E.M. Alendronate for the prevention of bone loss in patients on inhaled steroid therapy/ E.M. Lau, J. Woo, Y.H. Chan, M. Li // Bone.- 2001.-V.29.- P.506-510.

120.Ledford D. Osteoporosis in the corticosteroid-treated patient with asthma / D. Ledford, A. Apter, A.M. Brenner, et al. // BNJ. Allergy Clin. Immunol.- 1998.- V.103.- P.353-362.

121.Lckamwasam S. An association between respiratory function and bone mineral density in women from the general community: a cross sectional study / S. Lekamwasam, D.P. Trivedi, K.T. Khaw И Osteoporos. Int.- 2002.- V.13.- P.710-715.

122.Lespessailles E. Long-term corticosteroid therapy induces mild changes in trabecular bone texture / E. Lespessailles, V. Siroux, S. Poupon, et al. // J. Bone Miner. Res.- 2000.- V.15.- P.747-753.

123.Li G.T.C. Fluticasone propionate powder and lask of clinically significant effects on hypothalamic -pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma / G.T.C. Li, L.B. Ford, P.Chervinsky, et al. // J. Allergy Clin. Immunol.- 1999.- V.103.- P. 1062-1068.

124.Lill C.A. Effect of ovariectomy, malnutrition and glucocorticoid application on bone properties in sheep: a pilot stady/ C.A. Lill, A.K. Fluegel, E. Schneider // Osteoporos. Int.- 2002,- V.13.- P.48'0-486.

125.Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis / B.J. Lipworth // Arch. Intern. Med.- 1999.- V.159.- P.941-955.

126.LoCascio V. A histomorphometric long-erm longitudinal study of trabecular bone loss in glucocorticod-treated patients: prednisone versus deflazacort V. LoCascio, P. Balanti, S. Milani, et al // Calcif. Tissue Int-1998.- V.62.- P. 199-204.

127.Lofman O. Bone mineral density in normal Swedish women/ O. Lofman, L. Larsson, G. Ross, et al. // Bone.- 1997.- V.2.- P. 167-174.

128.Luengo M. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case control study / M. Luengo, L. Del-Rio, F.Pons, et al. // Eur. Respir. J.- 1997.- V.10.- P.2110-2113.

129.Lukert B. Glucocorticoid-induced osteoporosis: patogenesis and management/ B. Lukert, I.G. I.G. Rainz//Ann. Intern. Med.- 1990.-V.112.-P.353-364.

130.Lukert B. Glucocorticoid-induced osteoporosis/ B. Lukert, I.G. Rainz // Hosp. Pract.- 1995.- V. 8.P.45-47

131.Lunt M. Population-based geographic variationsin DXA bone density in Europe: the EVOS study/ M. Lunt, D. Felsenberg, J. Adams, et al. // Osteoporos. Int.- 1997.- V.7.- P.175-189.

132.Luppen C.A. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits/ C.A. Luppen, C.A. Blake, K.M.

Ammirati, et al. //J. Bone. Miner. Res.- 2002.- V.17.- P.301-310.

133.Luton J.P. Reversible gonadotrophin deficiency in male Cushings disease / J.P. Luton, P. Thieblot, J.C. Valcke, et al. //J. Clin. Endocrinol. Metab.- 1977.- V.45.- P.488-495.

134.Manolagos S.C. Bone marrow, cytokines, and bone remodeling / S.C. Manolagos H New. Engl. J. Med.- 1995.- V. 332.- P. 305-311.

135.Manolagos S.C. New developments in the patogenesis and treatment of steroid- induced osteoporosis/ S.C. Manolagos, R.S. Wienstein // J. Bone Miner. Res.- 1999.- V.14.-P.1061-1066.

136.Martinati L.C. Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclametasone dipropionate or cromolyn sodium/ L.C. Martinati, F. Bertolodo, D. Gasperi., et al. //Allergy.- 1998.- V.53.- P.705-708.

137.Matkovic V., Kostial K., Simonovic I., et al. Bone status and fracture rates in two regions of Yugoslavia 11 Am. J. Clin. Nutr.- 1979.- Vol.32.- P.540-549.

138.May H. Alcohol consumption and bone mineral density in older men/ H. May, S. Murphy, K.T. Khwan // Gerontology.- 1995,- V.41.- P.l 52-158.

139.Mazess RB. On aging bone loss // Clin. Orthop.- 1982.- Vol. 165.-P. 239-252.

140.McGrother C.W. Evaluation of a hip fracture risk score for assessing elderly women: The Melton Osteoporosis Fracture (MOF) Study/ C.W. McGrother, M.M.K. Donaldson, D. Clayton, et al. //Osteoporos. Int.- 2002.- V.13.- P.89-96.

141.McEvoy C.E. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease/C.E. McEvoy, K.E. Ensrud, T. Bender, et al. // Am. J. Respir. Crit Care Med.- 1998.- V.57.- P.704-709.

142.McLeod J.F. Osteoporosis, cytokines, and glucocorticoids I J.F. McLeod //Allergy Proc.- 1993.- V.14(5).- P.363-364.

143.Miller P.D. Biphosphonates for the prevention and treatment of corticosteroid- induced osteoporosis / P.D. Miller//Osteoporos. Int.- 2001- V.12.- Suppl. 3: 17-22.

144.Mudano F. Variations in glucocorticoid-induced osteoporosis prevention in a managed care cohort/ F. Mudano, J. Allison, B. Rothermel, K. Saag // J. Rheumatol.- 2001.- V.28.- P.1298-1305.

145.Muratore M. Prevention with clodronate of osteoporosis secondary to inhaled corticosteroid treatment in patients with asthmatic bronchitis /М. Muratore, G. Santacesaria, E. Quarta, et al. И Int. J.CIin. Pharmacol. Res.- 2000.- V.20(3-4).- P.61- 64.

146.National Osteoporosis Foudation. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. // Osteoporos Int.- 1998.- V.8.- Suppl. 4.- S1-S88.

147.Need A.G. Relationships between intestinal calcium absorption and serum vitamin D metabolites and smoking in postmenopausal women/ A.G. Need, A. Kemp, N. Giles, et al. // Osteoporos. Int- 2002.- V.13.- P.83-88.

148.Nielsen H.K. The effects of short-term high dose treatment with prednisone on the nuclear uptake of 1.25- dixydroxyvitamin D3 in monociytes from normal human subjects /Н.К. Nielsen, E.F. Ericsen, T. Stom, L. Mosekilde // Metabolism.- 1988.-V. 37.- P.109-114.

149.Nishimura Y. Bone mineral content in patient with bronchial asthma/ Y. Nishimura, H. Nakata, H. Maeda, M. Yokoyama // Nihon. Kyobu. Shikkan. Gakkai. Zasshi.- 1995.- V.33.- P.300-305.

150.Nishizawa Y. Gudelines on the use of biochemical markers of bone turnover in osteoporosis / Y. Nishizawa, T. Nakamura, H. Onata et al.// J. Bone Miner. Metab.- 2001.-V.l 9.-P.338-344.

151.Orwoll E.S. Osteoporosis in Men / E.S. Orwoll // Bone.- 2001.- V.28.- Suppl. 5 - IN4.- S66.

152.Papadimitropoulos E.A. Current and projected rates of hip fracture in Canada / E.A. Papadimitropoulos, P.C. Coyete, R.G. Josse, C.E. Greenwood // Can. Med. Assos. J.- 1997.-V.I57.- P. 1357-1363.

153.Papaioannou A. Mortality, independence in living , and refracture one year following hip fracture in Canadians / A. Papaioannou, M. Wiktorowicz, J.D. Adachi, at al. // J. Soc. Obstet. Gynacol. Can.- 2000.- V.22.- P.591-597.

154.Patschan D. Molecular mechanisms of glucocorticoid-induced osteoporosis/ D. Patschan, K. Loddenkemper, F. Buttgereit//Bone.- 2001.- V.29.- P.498-505.

155.Pearce G. Corticosteroid-induced bone loss in men / G. Pearce, D.A. Tabensky, P.D. Delmas et al. //J. Clin. Endocrinol. Metab.- 1998.- V.83.- P.801-806.

156.Pols N.A. Epidiological aspects of osteoporosis in men and women/ N.A. Pols // Bone.- 2001.-V.28.- Suppl.5.- IN4.- S67.

157.Puente Maestu L. Corticosteroid treatment and osteoporosis/ L. Puente Maestu //Eur. Respir. Top.-1998.- V.4.- P.31-32.

158.Reid I.R. Preventing glucocorticoid-induced osteoporosis / I.R.Reid // N. Engl. J. Med.- 1997.- V.337.- P.420-421.

159.Reid I.R. Testosterone therapy in glucocorticoid -treated men И I.R. Reid, D.J. Wattie, M.C. Evans, J.P. Stapleton//Arch. Intern. Med.- 1996.- V.156.- P.l 173-1177.

160.Reid D.M. Risk stratification by peripheral bone mass comparison of random population screening and selection by clinical risk factors/ D.M. Reid, R. Hughes, W.D. Fraser, et al. И Bone. - 2001. - V. 28. - №5. - P.195.

161.Ringe J.D., Dorst A.J. Osteoporosis in the men: diagnosis and therapy // Ther. Umsch.- 1998.- Vol.55.-№11.- P. 717-723.

162.Ruegsegger P. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography/ P. Ruegsegger, T.C. Medici, M. Anliker // Eur. J. Clin. Pharmacol.- 1983.-V.25.- P.615-620.

163.Robinson R.J. The effect of rectally administered steroids on bone turnover: a comparative study/ R.J. Robinson, S J. Igbal, R. Wolfe, et al. // Aliment. Pharmacol. Ther.- 1998.- V.12.-P.213-217.

164.Rothberg A.D. Monitoring and management of bone status in patients on chronic glucocorticoid treatment - the Medschene experience/ A.D. Rothberg, P.K. Matshidze // S. Afr. Med. J.- 2000.- V.90(11).- P.l 111-1112.

165.Saag K.G. Low dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence/ K.G. Saag // Am. J. Med.- 1997.- V.103.- P.31S-39S.

166.Saito J.K. Users of low dose glucocorticoids have increased bone loss rates: a longitudinal study/ J.K. Saito, J.W. Davids, R.D.Wasnich, et al. //Calcif. Tissue Int.- 1995.- V.57.- P.115-119.

167.Sakakura M. Inhibition of luteinizing hormone secretion induced by syntetic LRH by long-term treatment with glucocorticoids in human subjects / M. Sakakura, K. Takebe, S. Nakagava//J. Clin. Endocrinol. Metab.- 1975.- V.40.- P.774-779.

168.Sambrook H.N. Prevention of corticosteroid osteoporosis; a comparison of calcium, calcitrol and calcitonin / H.N. Sambrook, J. Birmingham P.J. Kelly, et all. // N. Engl. J. Med.- 1993.-V. 328.- P.1747-1752.

169.Seeman E. Production degradation and circulating levels of 1.25 dihydroxyvitamin D in health and chronic glucocorticoid excess/ E. Seeman, R. Jkumar, G.G. Hunder, et al. //J. Clin. Invest.- 1980.- V.66.- P.664-669.

170.Selby P.L. Corticosteroids do not alter the threshold for vertebral fractures/ P.L. Selby, J.P. Halsey, K.R.H. Adams, et al. // Bone.- 1998.- V.23(Suppl).- SI59.

171.Simonet W.S. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density / W.S. Simonet, D.L. Laccy, C.R. Dunstan, et al. //Cell.-1997.- V.89.- P.309-319.

172.Siroux V. Bone densitometry and fractures in long term corticosteroid therapy: a study in 130 cases /V. Siroux, N. Andrimbelosoa, E. Lespessailles, C.L. Benhamou // Bone.- 1998.- Suppl.23.- S487.

173.Smith B.J. Does beclamethasone dipropionate suppress dehydroepiandrosterone sulphate in postmenopausal women? I B.J. Smith, J.R. Buxton, J. Dickenson, R/F/ Heller // Aust N. Z. J. Med.- 1994.- V.24(4).- P.396401.

174.Tattersfield A£. Bone mineral density in subjects with mild asthma randomized to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years / A.E. Tattersfield, G.I. Town, D.Johnell//Thorax.- 2001.-V.56.-P.272-278.

175.Teeluksingh S. Inhaled steroids, bone formation and osteocalcin / S. Teeluksingh, P.L. Radfield, L. Tibi //Lancet.- 1991.- V.l 10.- P.60-61.

176.Thomsen O.O. A comparison of budesonide and mesalamine for active Crohn's disease/ O.O. Thomsen, A. Cortot, D. Jewell, et al. // N. Engl. J. Med.- 1998.- V.339.- P.370-374.

177.Toogood J.H. Side effects of inhaled corticosteroid /J.H. Toogood // J. Allergy. Clin. Immunol.- 1998.- V.102.- P.705-713.

178.Tsugeno H. Bone mineral density in steroid- depended asthma assessed by peripheral quantitative computed tomography/ H. Tsugeno, M. Nakai, M.Okamoto, et al. // Eur. Respir.- 1999,- V.14.- P.923-927.

179.Tsugeno H. Oral glucocorticoid-induced fall in cortical bone volum and density in postmenopausal asthmatic ’patients/ H.Tsugeno, B. Goto, M. Fujita, et al. // Osteoporos. Int-2001.-V.12.- P.266-270.

180.Tsugeno H. Vertebra, fracrure and cortical bone changes in corticosteroid- induced osteoporosis/ H. Tsugeno, T. Fujita, B. Goto, et al. // Osteoporos. Int.- 2002,- V.13.- P. 650-656

181.Tuck S.P. Is distal forearm fracture in men due to osteoporosis? I S.P. Tuck, G.D. Summers, J.S. Harrop, J.N.V. Miles // Bone.-2001.- V.28.- Suppl. 5.- SC27S.- S96.

182.Udagava N. Interleukin-18 (interferon-[{gamma}]- inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-[{gamma}] to inhibit osteoblast formation I N. Udagava, N.J. Horwood, J. Elliot, et al. //J. Exp. Med.- 1997.- V.185.- P.1005-1012.

183 .Van Staa T.P. Use of corticosteroids and risk of vertebral fractures/ T.P. Van Staa, Y.G. Leufkens, L. Abenhaim, et al. // J. Bone Miner. Res.- 2000.- V.15.- P.993-1000

184.Van Staa T.P. Use of inhaled corticosteroidsand risk of fractures/ T.P. Van Staa, Y.G. Leufkens, C. Cooper//J. Bone Miner. Res.- 2001.- V.16.- P.581-588.

185.Van Staa T.P. The epidemilogy of corticosteroid-Iidused osteoporosis: a meta­analysis/ T.P. Van Staa, Y.G. Leufkens, C. Cooper // Osteoporos. Int.- 2002.- V.13.- P.777-787.

186.Ward M.J. Inhaled corticosteroid: effect on bone? I M.J. Ward // Respir. Med.- 1993.- V.87 (suppl А).- Р.ЗЗ-І6

187.Wienstein R.S. Inhibition of osteoblastogenesis and promotion of-apoptosis of osteoblasts and osteocytes by glucocorticoids/ R.S. Wienstein, R.L. Jilka, A.M. Parfitt, S.C. Manologas // J. Clin. Invest.- 1998.- V.102.- P.274-282.

188.Wiktorowitcz M.E. Economic implications of hip fracture: Health servise use, institutional care and cost in Canada/ M.E. Wiktorowitcz, R. Goeree, F. Papaioannou, at al. И Osteoporos. Int.- 2001.-V. 12.- P.271-278.

189.Wishniewski A.F. Cross sectional investigation of the effects of inhaled corticosteroids on bone density ahd bone metabolism in patients with asthma / A.F. Wishniewski, S.A. Lewis, D.J. Green, et al. // Thorax.- 1997.-V. 52.- P.853-860.

190.Wong C.A. Inhaled corticosteroid use and bone-mineral density in patients with asthma / C.A. Wong, L.J. Walsh, C.J. Smith, et al. // Lancet.- 2000.- V.355.- P.l 399- 1403.

191.Woo J. Population bone mineral density measurements for Chinese women and men in Hong-Kong/ J. Woo, M. Li, E. Lau // Osteoporos. Int- 2001.-V 12.- P.289- 295.

192.Yasuda N. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPDI N. Yasuda, K. Gotoh, S. Minatoguchi //Respir. Med. -1998.- V.92.-Suppl.8.- P.993-999.